Craig R. Fairchild - Concepedia

Author

Craig R. Fairchild

Bristol-Myers Squibb (United States)

Also Known As

C R Fairchild, CRAIG FAIRCHILD, Craig Fairchild, Craig R Fairchild, Craig R. Fairchild

131

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)University of the South Pacific Georgia Institute of Technology University of Illinois Chicago

About

Craig R. Fairchild is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	43	3.3K
2	Natural Sciences	19	21	1.7K
3	Biochemistry	17	18	1.6K
4	Engineering	4	4	317
5	Health Sciences	1	1	13

Craig R. Fairchild

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Francis Y. F. Lee, R. M. Borzilleri, Craig R. Fairchild, PubMed PharmacotherapyTumor BiologySuperior Antitumor EfficacyTubulin MutationNovel Epothilone Derivative	2001	455
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Jeffrey A. Moscow, Craig R. Fairchild, Mary Madden, PubMed GlycobiologyPathologyP-glycoprotein GenesCancer BiologyTumor Biology	1989	352
Eleutherobin, a New Cytotoxin that Mimics Paclitaxel (Taxol) by Stabilizing Microtubules Thomas Lindel, Paul R. Jensen, William Fenical, Journal of the American Chemical Society Drug TargetToxinologyAltmetric Attention ScoreCytoskeletonChemical Biology	1997	294
Stephacidin A and B: Two Structurally Novel, Selective Inhibitors of the Testosterone-Dependent Prostate LNCaP Cells Jingfang Qian‐Cutrone, Stella Huang, Yue‐Zhong Shu, Journal of the American Chemical Society Secondary MetaboliteSelective InhibitorsPharmacotherapyNovel AlkaloidsPharmaceutical Chemistry	2002	221
Silvestrol and Episilvestrol, Potential Anticancer Rocaglate Derivatives from <i>Aglaia silvestris</i> Bang Yeon Hwang, Bao-Ning Su, Heebyung Chai, The Journal of Organic Chemistry	2004	191
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes Greg A. Kicska, Long Li, Heidi Hörig, Proceedings of the National Academy of Sciences	2001	187
Novel Strategies for the Discovery of Plant-Derived Anticancer Agents A. Douglas Kinghorn, Norman R. Farnsworth, Djaja D. Soejarto, Pharmaceutical Biology	2003	179
Discovery of Aminothiazole Inhibitors of Cyclin-Dependent Kinase 2: Synthesis, X-ray Crystallographic Analysis, and Biological Activities Kyoung Soon Kim, S. David Kimball, Raj N. Misra, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetCdk2 ProteinCompound 14Heterocycle Chemistry	2002	156
Transfection with Protein Kinase Cα Confers Increased Multidrug Resistance to MCF-7 Cells Expressing P-Glycoprotein Gang Yu, Shakeel Ahmad, Angelo Aquino, Cancer Communications Chemoprevention StrategyMultidrug ResistanceCellular PhysiologyDrug ResistanceMolecular Pharmacology	1991	145
A Novel Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products R. M. Borzilleri, Xiaoping Zheng, Robert J. Schmidt, Journal of the American Chemical Society Several LactamEngineeringOrganic ChemistryChemistryPharmaceutical Chemistry	2000	141

Page 1